Business

Announcement on Voluntary Disclosure of Permission Granted by the Australian Authorities for the Initiation of Phase I Clinical Trials of APL-2401

Announcement on Voluntary Disclosure of Permission Granted by the Australian Authorities for the Initiation of Phase I Clinical Trials of APL-2401

articleJiangsu Yahong Meditech Co., Ltd. Class AJanuary 22, 20265/news/announcement-on-voluntary-disclosure-of-permission-granted-by-the-australian-authorities-for-the-initiation-of-phase-i-clinical-trials-of-apl-2401
Announcement on Voluntary Disclosure of Permission Granted by the Australian Authorities for the Initiation of Phase I Clinical Trials of APL-2401

About this update from Jiangsu Yahong Meditech Co., Ltd. Class A

Announcement on Voluntary Disclosure of Permission Granted by the Australian Authorities for the Initiation of Phase I Clinical Trials of APL-2401 The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Jiangsu Yahong Meditech Co., Ltd. Class A